s6y
Company name or ticker
Search
CymaBay Therapeutics, Inc.
SC 13G/A
TCG Crossover GP I, LLC: Major shareholder report (passive investor)
Filed
Tuesday, February 13, 2024
Accession number
0001193125-24-033789
Subject company
CymaBay Therapeutics, Inc.
Filed by
TCG Crossover GP I, LLC
Documents
Major shareholder report (passive investor)
SC 13G/A
Certifications, consents and other formalities
1
Power of attorney
24
Power of attorney
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header